Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract. The Expect Needle received FDA clearance and CE Mark approval earlier this year and is being marketed in the U.S., Europe and other international markets.

9 May 2011

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Epigenomics AG, the cancer molecular diagnostics company, reports that Dr. Uri Ladabaum, Associate Professor in the Department of Gastroenterology and Hepatology at the School of Medicine of Stanford University, has presented the results of a health economic analysis of potential future colorectal cancer screening with Septin9 blood tests at the ongoing Digestive Disease Week 2011.

9 May 2011

Season-of-birth factors can cause celiac disease in Massachusetts children

Celiac disease is more common among Massachusetts children born in the spring or summer, and this higher incidence could be related to the intersection of key seasonal and environmental factors, according to researchers at the Massachusetts General Hospital for Children.

9 May 2011

Innovative detection practices may prevent liver diseases

Research being presented at Digestive Disease Week- shows that screening individuals for hepatitis C based on age instead of conventional risk factors may help increase detection rates as well as prevent liver disease.

9 May 2011

Socioeconomic status may contribute to celiac diagnostic disparity

Income is a pivotal factor in whether a patient without common symptoms of celiac disease is accurately diagnosed with the digestive condition, according to a new study from the Beth Israel Deaconess Medical Center in Boston, MA.

9 May 2011

Adalimumab remains in newborn's bloodstream for at least three months

Adalimumab, a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers at the University of California San Francisco have found.

9 May 2011

Research offers further evidence that diet affects gastrointestinal illnesses

Research being presented at Digestive Disease Week- offers further evidence that diet affects gastrointestinal illnesses, such as gallstones and celiac disease, and that some patients who think their digestive problems are caused by lactose intolerance are actually reacting to a psychological disorder.

9 May 2011

Parasites in human waste fertilizers alarm health experts

It has been suggested that human faeces used as fertiliser on farms are leading to the spread of ‘Third World’ parasites causing a serious stomach illness across Sydney.

8 May 2011

Scientists to identify host bacteria that colonize different hybrids

Literature tells us that "no man is an island entire unto itself," but science reveals that we are in fact a walking, talking colony of microscopic creatures.

7 May 2011

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week- 2011, the largest and most prestigious gastroenterology meeting, from May 7-10, 2011, at McCormick Place, Chicago, IL.

7 May 2011

American Gastroenterological Association, Horizon Pharma announce 2011 abstract prize recipients

The American Gastroenterological Association Research Foundation today announced Horizon Pharma's support of research awards aimed to stimulate interest in gastroenterology/hepatology research careers through competition and recognition.

6 May 2011

AGA honors four young gastroenterologists with prestigious Research Scholar Awards

The American Gastroenterological Association Research Foundation has announced its 2011 research scholars. The grants have been awarded to four outstanding young gastroenterologists who promise to make significant strides in the field of gastrointestinal research.

6 May 2011

H. pylori DNA may help treat severe colitis

DNA from Helicobacter pylori, a common stomach bacteria, minimizes the effects of colitis in mice, according to a new study by University of Michigan Medical School scientists.

6 May 2011

Fecal transplant procedures performed at Sinai Hospital

Sudhir Dutta, M.D., head of the Division of Gastroenterology at Sinai Hospital, performed fecal transplant procedures for two patients with severe clostridium difficile (C. difficile) colitis that did not respond to routine antibiotic and other treatments. C. difficile causes symptoms ranging from mild diarrhea to more serious, sometimes life threatening colon inflammation.

5 May 2011

Devrom is effective for eliminating flatulence, stool odor issues

Flatulence. Everyone has it. Common factors contributing to flatus production are swallowed air and digestion of certain foods in the intestine. Perhaps one of the most embarrassing aspects of flatulence is the smelly odor, but there is a remedy and it is called Devrom.

5 May 2011

Childhood cancer survivors may face high risk of late GI complications after therapy

Patients who received therapy for cancer during childhood have an increased risk of developing gastrointestinal complications later in life, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

5 May 2011

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

Santarus, Inc. today announced that the budesonide MMX Phase III clinical program will be featured in two oral presentations at the Digestive Disease Week Meeting being held at McCormick Place in Chicago on May 7-10, 2011.

3 May 2011

Ipsen first quarter sales increase 6.1% to €285.8 million

Ipsen reported today its sales for the first quarter 2011.

3 May 2011

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.

3 May 2011

Porter Adventist Hospital introduces new institute for robotic surgery

Robotic surgery, once the stuff of science fiction, has for some years been recognized as an important advance in surgical technique and patient experience. Now, at Porter Adventist Hospital, a comprehensive team of surgeons and staff are helping to bring in a new era in robotic surgery.

2 May 2011